Annual Drug Patent Expirations for OSPHENA
Osphena is a drug marketed by Duchesnay and is included in a single NDA. It’s obtainable from one provider. There are eight patents defending this drug.
Drug patent litigation for OSPHENA.
This drug has eigthy-three patent members of the family in thirty-one nations.
The generic ingredient in OSPHENA is ospemifene. One provider is listed for this compound. Extra particulars can be found on the ospemifene profile web page.
For extra data on how DrugPatentWatch might help together with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com
Make Higher Choices with DrugPatentWatch
Copyright © DrugPatentWatch. Initially printed at New patent expiration for Duchesnay drug OSPHENA